Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Proliferative Vitreoretinopathy
Clinical trial NCT07162818 · COMPLETED
Trial details
- NCT number
- NCT07162818
- Sponsor
- Indonesia University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2021-12-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.